Pharmaceutical and nutraceutical syrups, suspensions and drops filled at our WHO-GMP facility in Ahmedabad — the dosage form for paediatric, geriatric and any patient who cannot swallow a tablet.
Clear syrups for soluble actives and suspensions for those that are not. Sugar-based or sugar-free, with the sweetener system chosen for your target user.
Concentrated drops with a calibrated dropper or measured pipette — the format for infant vitamin D and paediatric dosing where volume must be small and accurate.
Filled in appropriate containers under the controls these routes demand. Scope confirmed per project against the applicable licence.
For this dosage form the minimum is driven by pack format and vessel capacity, so a single published figure would mislead more than it helped. Send the pack size and volume and we confirm a written MOQ at the feasibility stage, before any commitment.
Our published minimums for tablets, capsules, soft gels and sachets are 3,000 units per SKU for an existing formulation and 10,000 for a new one — see the full MOQ table.
| Forms | Syrup, suspension, oral drops, eye and nasal drops |
|---|---|
| Sweetening | Sucrose-based or sugar-free (sorbitol, sucralose) for diabetic and low-calorie positioning |
| Containers | PET and amber glass bottles; amber where the active is light-sensitive |
| Closures | Child-resistant caps, measuring cups, calibrated droppers and measured-dose pipettes |
| Typical products | Multivitamin syrups, iron tonics, calcium suspensions, paediatric vitamin D drops, cough preparations |
Every batch is released against a written specification and shipped with a Certificate of Analysis listing each test, its limit and the actual result.
| Test | What it confirms |
|---|---|
| Description | Colour, clarity or uniformity of suspension, odour and taste |
| pH | Drives both stability and palatability |
| Viscosity | The syrup pours and doses as intended |
| Fill volume | Each bottle contains the declared volume |
| Assay of actives | Content of each declared active against label claim |
| Redispersibility | A suspension re-suspends on shaking rather than caking at the bottom |
| Microbial limits & preservative efficacy | Liquids carry higher microbial risk than any dry form — per pharmacopoeia and FSSAI |
Quoted per project. Liquid MOQ depends on bottle size, batch vessel capacity and whether the container is PET or glass, so a single published number would mislead more than it helped. Send the pack size and volume and we confirm a written MOQ at the feasibility stage, before any commitment.
Yes — sorbitol and sucralose systems for diabetic and low-calorie positioning. Sugar-free changes mouthfeel as well as sweetness, so the flavour system is reworked rather than simply swapped, and you approve samples before commercial production.
PET is lighter, cheaper and survives transport better. Amber glass protects light-sensitive actives and reads as more premium. If your active degrades under light, the decision is made for you — otherwise it is a cost and positioning call.
Liquids carry higher microbial risk because water supports growth, so preservative efficacy and microbial limits matter more. Suspensions are additionally tested for redispersibility — whether the product re-suspends on shaking rather than caking permanently at the bottom of the bottle.
One Ahmedabad facility across every form below, so a multi-SKU range stays with a single accountable manufacturer. See all capabilities on the contract manufacturing overview.
Tell us your product idea, target dosage form, and projected volumes in the form above. Our team will respond within one business day with a feasibility note and indicative pricing.
Send a manufacturing briefOr call +91 94279 85519